Gufic Biosciences has incorporated a subsidiary Company in India namely ‘Gufic Prime’ on November 18, 2023. Gufic Prime shall carry on the business of manufacturing, marketing, distribution and sale of pharmaceutical products. The Cost of subscription of shares would be Rs 88,000 (88,000 equity shares of face value of Rs 1 each). Gufic Prime is yet to commence its business operation.
Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.
